SEMA3A and amyotrophic lateral sclerosis: Taken together with the increase of Sema3A in the motor cortex of postmortem ALS patients and the tendency for lower expression in the spinal cord of postmortem ALS patients, our results imply that Sema3A functionally contribute to the pathology of ALS both at the level of the motor cortex and the level of the spinal cord.